Question 1

How does EquitAI evaluate U.S. Physical Therapy, Inc.'s (USPH) valuation and Stock DNA?

Accepted Answer

U.S. Physical Therapy, Inc. (USPH) trades at $85.83 with an EquitAI Valuation DNA score of 2/10 and Quality score of 7/10. The company's trailing P/E ratio is 504.9x. These scores evaluate balance sheet leverage, free cash flow generation, and fundamental multiples against historical benchmarks.

Question 2

What sector and industry does U.S. Physical Therapy, Inc. (USPH) operate in?

Accepted Answer

U.S. Physical Therapy, Inc. (USPH) is classified under the Healthcare sector within the Medical - Care Facilities industry. EquitAI benchmarks its fundamental valuation and financial DNA metrics against both direct Medical - Care Facilities peers and broader Healthcare market benchmarks.

Question 3

What is Wall Street's price target and consensus rating for U.S. Physical Therapy, Inc. (USPH)?

Accepted Answer

Wall Street analysts have a consensus 12-month price target of $90.0 for U.S. Physical Therapy, Inc. (USPH), representing an implied 4.9% upside from its current trading level of $85.83 with an average rating of Buy based on 2 analyst ratings. EquitAI benchmarks analyst consensus projections against intrinsic Financial DNA valuation pillars.

Question 4

Does USPH pay dividends or capital distributions?

Accepted Answer

U.S. Physical Therapy, Inc. has an indicated annual dividend yield of 2.13%. Dividend stability is factored into its Income DNA pillar alongside free cash flow coverage.

Question 5

Who are U.S. Physical Therapy, Inc.'s (USPH) primary market competitors and peers?

Accepted Answer

Key market peers and semantic competitors include CHCT, SGRY, HCWC, UHT. EquitAI maps peer relationships through semantic business models, institutional capital flow correlation, and market capitalization weighting.

Question 6

How should investors interpret EquitAI's USPH analysis?

Accepted Answer

EquitAI provides quantitative financial research, algorithmic DNA scores, and SEC contextual analytics for informational and research purposes. It does not constitute personalized financial advice or broker-dealer investment recommendations.

USPH - U.S. Physical Therapy, Inc. Stock Analysis & Valuation

U.S. Physical Therapy, Inc.

FIT ANALYSIS